NAMS vs SYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

NAMS

53.4
AI Score
VS
SYRE Wins

SYRE

55.7
AI Score

Investment Advisor Scores

NAMS

53score
Recommendation
HOLD

SYRE

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NAMS SYRE Winner
Net Income -112.58M -151.72M NAMS
Operating Income -123.28M -147.31M NAMS
ROE -17.8% -46.3% NAMS
ROA -16.0% -36.0% NAMS
Total Assets 704.45M 421.09M NAMS
Cash 424.15M 71.58M NAMS
Current Ratio 9.03 7.32 NAMS

Relative Price Performance (Last 90 Days)

NAMS 1M: -9.3% · 3M: -33.5% SYRE 1M: +7.1% · 3M: +5.0%

Current Technical Phase

NAMS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.9%), weak momentum, RSI 44

RSI (14): 44.2 · Price: $23.20

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.3 · Price: $93.19

Fundamentals Snapshot

Metric NAMS SYRE
Market Cap — —
Forward P/E -15.0 -26.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.8% 0.0%
Gross Margin 1.0% —
Operating Margin -17.5% 0.0%
EPS -2.16 -1.94
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.